Accumulating evidence has demonstrated that PGAM1 is upregulated in some types of tumors, including gliomas [4], bladder cancer [5], non‐small cell lung cancer (NSCLC) [6], and renal clear cell carcinoma [7]. Here, PGAM1 is linked to central nervous system cancer.